View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, explores the data to support the use of tenofovir alafenamide in pregnancy.
Listen as she gives her perspectives on:
Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois
This program has been made available online.
Discussion of key considerations for switching antiretroviral therapy when the patient is pregnant, from Clinical Care Options (CCO)
Annette Haberl, MD
William R. Short, MD, MPH, AAHIVS
Released: November 23, 2022
Dr Yan Zhao discusses data from IDWeek 2022 on long-term benefits of early vs delayed treatment initiation in people with HIV, from Clinical Care Options (CCO)
Yan Zhao, MD
Released: November 22, 2022
Dr Milosz Parczewski discusses HIV Glasgow 2022 reports on the impact of the war in Ukraine on HIV care in Eastern Europe, from Clinical Care Options (CCO)
Milosz Parczewski, MD, PhD
Released: November 22, 2022
Expert discussion of HIV Glasgow 2022 data on optimizing islatravir dosing based on lymphocyte changes and IDWeek 2022 data on LA CAB + RPV real-world effectiveness in the US OPERA Cohort, from Clinical Care Options (CCO)
Brenda E. Crabtree Ramírez, MD
Released: November 22, 2022
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.